Vimarsana
Biggest News Aggregation in the World

Page 3 - Authorized Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Authorized Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Authorized Use Today - Breaking & Trending Today

EXCLUSIVE: GOP Senate Candidate Matt Dolan Outlines 'Eye-Opening' Trip To View Border Crisis - Vimarsana News

EXCLUSIVE: GOP Senate Candidate Matt Dolan Outlines 'Eye-Opening' Trip To View Border Crisis

Republican Ohio Senate candidate Matt Dolan is urging Congress and the executive branch to target Mexican drug cartels and their Chinese suppliers.

It's Long Past Time to Repeal Outdated Use of Military Force Resolutions - Vimarsana News

It's Long Past Time to Repeal Outdated Use of Military Force Resolutions

The House needs to follow Senate's lead in repealing the obsolete 1991 and 2002 Iraq Authorized Use of Military Force resolutions.

Midterm Polling, PayPal, and Patellas - Vimarsana News

Midterm Polling, PayPal, and Patellas

Plus: The editors consider Ye and social media, then field a question about the TARP bailouts during the 2008 fiscal crisis.

Source: reason.com
Ukraine, casinos, South Side politics: The Forecast, by Greg Hinz Crain's Juice - Vimarsana News

Ukraine, casinos, South Side politics: The Forecast, by Greg Hinz Crain's Juice

The week is starting out with a bang, as a local member of Congress moves to raise the ante for the U.S. in the Ukrainian war, and as Mayor Lori Lightfoot faces more fallout from the casino derby and the Whole Foods closure.

U.S. FDA Extends Review of Biologics License Application for REGEN-COV® (casirivimab and imdevimab) for Treatment and Prophylaxis of COVID-19 - Vimarsana News

U.S. FDA Extends Review of Biologics License Application for REGEN-COV® (casirivimab and imdevimab) for Treatment and Prophylaxis of COVID-19

/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended by three months...